earnings
confidence high
sentiment positive
materiality 0.75
Allurion Q1 revenue $5.6M, net operating loss narrows 36% YoY; maintains FY 2025 guide
ALLURION TECHNOLOGIES, INC.
2025-Q1 EPS reported
$0.20
revenue$5,580,000
- Q1 revenue of $5.6M (down 40% YoY); gross margin expanded to 75% from 73% YoY.
- Operating expenses fell 37% YoY to $11.4M; adjusted OpEx of $10.1M, down 45%.
- Net operating loss of $7.3M, down 36% YoY; adjusted loss $5.9M, down 48%.
- Cash balance $20.4M; FY 2025 revenue guidance reaffirmed at ~$30M with ~50% OpEx reduction.
- Completed Pre-PMA meeting with FDA; final PMA module submission expected by end of June 2025.